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Abstract
Background: Major depression affects twice as many women as men, but the underlying molecular mechanisms
responsible for the heightened female vulnerability are not known. The amygdala, composed of heterogeneous
subnuclei, participates in multiple functional circuits regulating emotional responses to stress. We hypothesized that
sex differences in molecular structure may contribute to differential mood regulation and disease vulnerability.
Findings: Using gene arrays followed by quantitative PCR validation, we compared the transcriptome profiles
between sexes in human and mouse amygdala. We now report sexually dimorphic features of transcriptomes in
the basolateral nucleus of the amygdala, and these features are highly conserved across species. A functional
analysis of differential gene expression showed that mitochondrial-related gene groups were identified as the top
biological pathways associated with sexual dimorphism in both species.
Conclusions: These results suggest that the basolateral amygdala is a sexually dimorphic structure, featuring a
regulatory cascade of mitochondrial function and circadian rhythm, potentially linked through sirtuins and
hormone nuclear receptors. Hence, baseline differences in amygdalar circadian regulation of cellular metabolism
may contribute to sex-related differences in mood regulation and vulnerability to major depression.
Introduction
Males and females differ in behavior and brain structure,
as well as in prevalence of neuropsychiatric disorders.
The greater prevalence of major depression and rapid
cycling bipolar disorder in women [1,2] highlights the
importance of studying potential mechanisms for sex
differences. Sex chromosome- and hormone-linked
genes may directly affect sexually dimorphic neurobiol-
ogy [3]. For example, sex hormones regulate the size of
the medial amygdala and bed nucleus of the stria termi-
nalis during development [4]. The lateral (LA) and basal
(basolateral; throughout the article we refer to human
BA and mouse BLA) nuclei of the amygdala have been
identified as critical sites for learned fear and emotion
regulation in healthy subjects and in patients with mood
disorders [5,6], but little is known about their sexual
dimorphism. The isolation of subnuclei from the
amygdala complex improves microarray sensitivity to
detect differences in gene expression by reducing sample
heterogeneity, and could facilitate the subsequent identi-
fication of genetic sex differences. To characterize sex
differences in the intrinsic molecular properties of the
amygdala, we examined the presence of sexually
dimorphic patterns of gene expression in the basolateral
nuclei of the amygdala using postmortem samples from
control human subjects and mice.
Methods
Human Brain Samples
Postmortem amygdala samples from 12 healthy male
controls and 12 healthy female controls (age = 39-64
years) were obtained from the University of Pittsburgh
Brain Donation Program (Table 1), as previously
described [6]. Male and female groups were matched in
pairs as closely as possible on the basis of RNA integrity,
p H ,p o s t - m o r t e mi n t e r v a l ,a g e ,a n ds e x ,a n dt h eg r o u p s
did not differ on any of these parameters (p > 0.05;
Table 1). All subjects died suddenly without prolonged
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to the light acetylcholinesterase (AChE)-stained LA
across species, human BA and mouse BLA contained
the heavy stained AChE-positive neuropil in the amyg-
dala [7,8], implying that human BA and LA anatomically
correspond to the mouse BLA and LA according to the
well-defined AChE boundaries. Hence, based on the dis-
tribution of AChE activity and thionin staining, human
l a t e r a l( L A )a n db a s a l( B A )a m y g d a l an u c l e iw e r e
defined and separately harvested from 20-μmc r y o s t a t
sections using a clean RNase-free pipette tip. All proce-
dures were approved by the University of Pittsburgh’s
Committee for the Oversight of Research Involving the
Dead and Institutional Review Board for Biomedical
Research.
Mouse Brain Samples
Brains from adult C57BL/6J mice (n = 5 per sex; pooled
by 2 from 10 mice/group, 3 months of age) were har-
vested, fresh frozen and cryo-sectioned at 20 μmo n
UV-treated laser-capture microscopy slides (Leica
Microsystems, Wetzlar, Germany). Sections on the slides
were dried and stored at -80°C until used. Lateral (LA)
to basolateral (BLA) amygdala nuclei were visualized
with rapid thionin staining and dissected with the Leica
LMD 6500 laser microdissection system. All mice were
maintained on a 12-hour light-dark cycle (lights on
06:00 and lights off on 18:00) with ad libitum food and
water. All procedures were approved by the University
of Pittsburgh Institutional Animal Care and Use Com-
mittee (protocol # 0911014A-2, Animal Assurance #
A3187-01).
RNA extraction for Microarray Samples
Total RNA was extracted using the RNeasy Plus Micro
Kit (QIAGEN, Valencia, CA) and processed for microar-
ray analysis according to manufacturer’sp r o t o c o l .R N A
samples were amplified with Illumina TotalPrep RNA
Amplification Kit (for human tissue; Illumina, San
Diego, CA) and Nugen WT-Ovation Pico RNA Amplifi-
cation System (for mouse tissue; NuGen, San Carlos,
CA). The fragmented labeled cRNA samples were pro-
cessed and hybridized to microarrays (Human HT-12v3
and MouseWG-6v2.0 BeadChips).
Array Data Analysis
For statistical analysis, the log2-transformed signal inten-
sities of probe-sets that passed the initial expression
filters (< 30% missing values, detection p-value > 0.1),
were extracted and renormalized to the same mean and
Table 1 Characteristics of matched human subjects
Female Group Male Group
Age Interval Age Interval
Pair Case (Years) Race (Hours) pH RIN Case (Years) Race (Hours) pH RIN
1 HU1282 39 W 24.5 6.8 7.5 HU604 39 W 19.3 7.1 8.6
2 HU1092 40 B 16.6 6.8 8.0 HU1047 43 W 12.0 6.6 9.0
3 HU627
a,b 43 B 14.1 7.1 7.0 HU857
a,b 48 W 16.6 6.7 8.9
4 HU567 46 W 15.0 6.8 8.9 HU1067
b 49 W 6.0 6.6 8.2
5 HU1280
a 50 W 23.5 6.7 7.7 HU1086
a,b 51 W 24.2 6.8 8.1
6 HU1391
a,b 51 W 7.8 6.6 7.1 HU852
a,b 54 W 8.0 6.8 9.1
7 HU686 52 W 22.6 7.1 8.5 HU1031
b 53 W 23.2 6.8 8.9
8 HU575 55 B 11.3 6.8 9.6 HU1122 55 W 15.4 6.7 7.9
9 HU1247 58 W 22.7 6.4 8.4 HU685 56 W 14.0 6.6 8.0
10 HU1318 58 W 18.8 6.7 7.4 HU852 54 W 8.0 6.8 9.1
11 HU568 60 W 9.5 6.9 8.7 HU551 61 W 16.4 6.6 8.3
12 HU1466
b 64 B 20.0 6.7 8.8 HU615 62 W 7.2 6.4 7.8
Matched samples processed for microarray:
AVG 51.3 17.2 6.8 8.1 52.1 14.2 6.7 8.5
STDEV 8.1 5.7 0.2 0.8 6.7 6.2 0.2 0.5
Matched LA for final array analysis:
AVG 52.4 17.9 6.8 8.4 52.4 13.5 6.7 8.4
STDEV 8.9 5.2 0.2 0.7 7.7 5.8 0.2 0.5
Matched BA for final array analysis:
AVG 50.9 18.3 6.8 8.3 52.9 13.2 6.7 8.4
STDEV 7.8 5.5 0.2 0.7 8.7 4.4 0.2 0.5
Samples from LA (marked
a) and BA (marked
b) processed but excluded due to lower microarray quality control; W = Caucasian; B = African American; RIN = RNA
integrity number; AVG = average; STDVE = standard deviation.
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of batch. Discovery threshold for male/female differ-
ences were applied in both species (two-tailed t-test p-
value < 0.05; > 20% effect size). Functional analyses
were performed on the identified gene list using the
Ingenuity Pathways Knowledge Base [9] and compared
across species.
Real-time Quantitative PCR (qPCR) Data Analysis
Separate RNA samples were reverse-transcribed using
QScript cDNA super mix (QuantaBioscience, Gaithers-
burg, MD) using a combination of oligo (dT) and ran-
dom primers. Each PCR reaction was performed in
triplicate and compared to three internal controls
(GAPDH, beta-actin and cyclophilin). All designed pri-
mer sequences were designed with Primer3Plus (Addi-
tional File 1, table S1). Results were calculated as the
geometric mean of relative intensities compared to the
three internal controls. Validation of the array results
was considered at p< 0.05, using one-tailed unpaired
t-test.
Results
Using exploratory criteria we generated large and infor-
mative parallel human/mouse transcriptome datasets
from male and female BA (BLA in mice) and LA nuclei
of the amygdala. As an internal control to assess the
sensitivity of the array approach, all detected Y-chromo-
some genes (male-specific) displayed significantly male-
biased expression, and expression of numerous X-linked
genes showed a female bias (Figure 1). In humans, 1335
sex-biased autosomal genes were identified in BA (Addi-
tional File 2, table S2), and fewer (n = 165) in LA (Addi-
tional File 3, table S3). In mice, ~1% of autosomal genes
displayed sex-biased expression (BLA, n = 515, Addi-
tional File 4, table S4; LA, n = 556, Additional File 5,
table S5).
To reduce false discovery and focus on the most rele-
vant changes, we characterized the functional and cross-
species relatedness of autosomal sex-biased gene sets
using the Ingenuity Pathways Analysis (IPA) database.
Mitochondrial-related functions were consistently identi-
fied among the top four most-represented pathways in
human BA (p< 1.57E
-06), mouse BA (p<8 . 3 7 E
-03)a n d
mouse LA (p< 6.72E
-02). Assembly of RNA Polymerase
III Complex was the only identified canonical pathway
in human LA and was at trend level (p < 0.1).
Within the mitochondrial-related functions, genes
encoding enzymes of the mitochondrial electron trans-
port chain (ETC) consistently displayed high male-biased
expression (Figure 2A). Also, two genes coding for mito-
chondria-localized sirtuins (SIRT3, SIRT5), which serve
as metabolic regulators of circadian rhythms by utilizing
NAD
+ [10], also showed similar high male-biased expres-
sion in human BA and mouse BLA. Of related interest
was the identification of sex-biased circadian rhythm sig-
naling in human BA (IPA, p< 5.39E
-04)a n dm o u s eL A
(p<3 . 5 4 E
-02), which included conserved high female-
biased expression of selected circadian clock genes (e.g.,
Period 2 and trend-level for CLOCK; Figure 2A). Intrigu-
ingly, as nuclear receptors link the circadian clock to
metabolism [11], retinoic acid orphan receptor b (RORB)
and thyroid hormone receptor a (THRA) displayed high
female-biased expression in human BA (RORB: average
log ratio [alr] = 0.29, p < 0.026; THRA: alr = 0.31,
p < 0.013).
The accuracy and reproducibility of the approach was
assessed by qPCR on independent samples. 12 genes out
of 18 tested were individually confirmed (p< 0.05; same
direction; Figure 2B). Overall, the qPCR validation
results were highly correlated with array data using
Pearson tests for significance (r = 0.86, p <2 . 5 E
-06;
Figure 2D).
We next evaluated the anatomical extent of the
observed sex-biased gene profiles in other brain areas
using existing human array data in cortical regions [12].
Numerous ETC and SIRT genes in dorsolateral prefron-
tal cortex (Brodman area 9 [BA9]; Figure 2C), and fewer
in the ventrolateral prefrontal cortex (Brodman area 47
[BA47]; Figure 2C) and anterior cingulate cortex (ACC;
Figure 2C), consistently displayed high male-biased
expression, suggesting variable levels of regional conser-
vation and amygdala enrichment.
Notably, within the limited cohort size and age range,
we did not observe statistically significant age-related
effects for genes confirmed by qPCR, except for male-
biased ATP synthase genes (ATP5A1, r =- 0 . 7 8 ,p <
0.005; ATP6VOD1, r = -0.58, p <0 . 0 5 )i nh u m a nm a l e
(number of genes)
Y-linked genes  0* / 13 13* / 13  0* / 13  13* / 13  0* / 5 5* / 5  0* / 6 6* / 6
X-linked genes 15* / 48 33* / 48  5* / 12 7* / 12  2* / 3  1* / 3 11* / 26  15* / 26
Sex Chromosome Genes
Human Mouse
BA LA BLA LA
Figure 1 Number of sex chromosome genes identified in the amygdala. Red: higher expressed in females; blue: lower expressed in females.
In each cell, each gene in the numerator differed significantly in expression (p< 0.05).
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 Gene Symbol BA LA BLA LA  Gene Symbol BA LA BLA LA  Gene Symbol BA9 BA47 ACC
 NDUFA2  -0.31
#  NDUFA2  -0.23
(NS)  NDUFAB1  -0.50**
 NDUFA8  -0.44*  NDUFA12  -0.28*
 NDUFA12  -0.43*  NDUFB2  -0.63**  SDHALP1  -0.37*
 NDUFB2  -0.39*  -0.32**  NDUFB6  -0.38 *  SDHD  -0.5*
 NDUFB3  -0.48*  NDUFS4  -0.47***
 NDUFB6  -0.52*  NDUFAB1  -0.45**  UQCRFS1  -0.51**
 NDUFC2   -0.46*  UQCRC2  -0.40*
 NDUFS3  -0.46**  UQCRFS1  -0.36*  -0.21*  -0.21**
 NDUFS4  -0.53*  ATP5A1  -0.37***
 NDUFS7  0.39*  COX7C  -0.56***  ATP5G3  -0.45*
 NDUFAB1  -0.41**  ATP5L  -0.37**
 ATP5A1  -0.28*  ATP6V0A1  -0.68*
 SDHA  -0.37*  ATP5J  -0.43
#  ATP6V0E1  -0.36*
 SDHB  -0.30
#  ATP6V0D1  -0.03
(NS)  ATP6V1A  -0.83**
 ATP6V1B2  -0.43**
 UQCRFS1  -0.51*  -0.32
#  -0.41**  PER2  0.38*  0.92*  ATP6V1C1  -1.15***
 UQCRC2  -0.41*  CLOCK  0.09
(NS)  1.02
#
 ATP6V1D  -0.39**
 UQCRH  -0.53*  -0.42
#  CRY1  -0.23
#
Note: h= human; m= mouse  SIRT3  -0.19***
 COX5B  -0.31* ൹: higher expressed in females   SIRT4  -0.12*  0.17**
 COX7B  -0.30* ൻ: lower expressed in females  SIRT5  -0.10***
 COX7C  -0.39*  Alr = average log ratio (F/M); * p<0.05; **p<0.01; ***p<0.001; # 0.05<p<0.1(trend)
 COX8A  -0.28*  
NS =Not Significant; bold-typed: gene validated by qPCR
 COX11  -0.35*
 COX17  -0.35*
 ATP5A1  -0.46*
 ATP5B  -0.28*
 ATP5E  -0.41
#
 ATP5H -0.27
 ATP5J  -0.43*  -0.29*
 ATP5O  -0.40
#  -0.34
#
 ATP5S1  -0.46*
 ATP1A2  -0.40*
 ATP6V0A1  -0.46
#
 ATP6V0B  -0.47
#
 ATP6V0C  -0.52*
 ATP6V0D1  -0.41**  -0.32*
 ATP6V1G1  -0.36*
 ATP6V1H  -0.52
#
 SIRT3  -0.46*
 SIRT5  -0.22*
 PER2  0.44*  0.42*
 CLOCK  0.27
#  0.33*
 CRY1  -0.29*
 CSNK1E  0.38*
Clock genes
Sirtuin
Clock genes
ATP synthase
ATP synthase
succinate dehydrogenase
ubiquinol-cytochrome c reductase
cytochrome c oxidase
ATP synthase
cytochrome c oxidase
NADH dehydrogenase
Human
ubiquinol-cytochrome c reductase
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Figure 2 Human-mouse conserved sexually dimorphic gene expression in the amygdala. Sexually dimorphic gene expression in human
BA/LA and mouse BLA/LA nuclei by microarray (A) and qPCR (B) analysis. (C) Sexually dimorphic gene expression in human BA9 and BA47. ALR
indicates female to male expression ratios (in log2). (D) Correlation summary graph of array/qPCR confirmation of differential gene expression.
(E) Schematized network of male-biased (blue) mitochondrial genes and female-biased (red) clock genes. Continuous contour indicates 12 sex-
biased genes confirmed by qPCR (p< 0.05). Dashed-lined contour indicates qPCR results at the trend level (p< 0.1). NHR = nuclear hormone
receptor.
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pause or estrogen replacement treatment for the human
female subjects, we interpret e dt h e s er e s u l t sa si n d i c a -
tive of sexual dimorphism independently of age or estro-
gen status, although this will need to be tested in larger
cohorts.
Discussion
We report sexually dimorphic gene expression profiles in
the BA nucleus of the amygdala in human subjects.
Changes at the level of single genes extend to homologous
BLA nucleus in the mouse amygdala, albeit to a lesser
extent. At the functional level, mitochondrial-related gene
groups were consistently identified as the top biological
pathways associated with male/female differences in both
species. Together with prominent differences in other
gene groups (Figure 2), our results suggest a sexual
dimorphism in the expression level of an evolutionarily
conserved pathway - circadian clock and mitochondrial
function, potentially linked through sirtuin and nuclear
hormone receptors.
In experimental models, circadian genes modulate
energy metabolism by setting the periodic oscillations of
expression and activity of enzymes to influence physiolo-
gical and behavioral functions. Substantial evidence has
shown that patients with major depression or bipolar dis-
order often display abnormalities in circadian rhythm,
such as disturbances in the sleep/wake cycle and diurnal
mood changes. Genetics studies have found associations
with CLOCK, PER1-3, and CRY1, and Sirtuin genes in
mood disorders [13-16]. In molecular/genetic studies,
mitochondrial dysfunction has been associated with
mood disorders [17,18], and mood disorders are common
in patients with mitochondrial disorders [19]. Thus, our
findings suggest that baseline sexual dimorphism in
mitochondrial density or functions may influence energy
availability in the amygdala. Notably, while mitochondrial
function was systemically identified as a top sex-biased
gene family across species, the species-specific ortholo-
gous genes were not necessarily and systematically the
same, but very close functionally (Figure 2E). Because of
identification of mitochondrial-related genes with closely
related functions and locations across species, we specu-
late that the sex-biased mitochondria profile may be
under conserved transcription control to display similar
sexual dimorphism across species.
Limitations of this study are noted. The results will
need to be confirmed at the protein and functional levels
in independent and larger cohorts. Similarly, the poten-
tial contribution of race-specific amygdala gene expres-
sion will need to be assessed in larger cohorts. It is also
unclear whether our findings in mid-life adults can be
generalized to adolescent and elderly populations. Here
we identified age effects in 2 of the 18 genes validated by
qPCR, suggesting that aging may not contribute to the
evolutionary conserved genetic sex differences in amyg-
dala. In addition, this study sampled 10 intact female
mice and 12 female human subjects from 39-64 years
old, which should considerably lower the impact of vari-
able estrogen levels on our findings of genetic sex differ-
ence, although we cannot exclude residual effects.
In conclusion, we present evidence for significant male/
female differences in amygdala gene expression across
species. Delineating the contribution of mitochondrial
and circadian signaling in mood disorders will require
additional work. For instance, sex-biased gene expression
of circadian clock, nuclear hormone receptors, mitochon-
drial sirtuins and electron chain enzymes in an interlock-
ing-feedback loop, may functionally translate into
differential amygdala responsiveness (Figure 2E). This
loop may lead to sex differences in metabolic capacity to
meet energy demand, and might potentially contribute to
the greater female vulnerability to mood disorders.
Additional material
Additional file 1: Table S1. Sequence of human and mouse primers
used for qPCR measurements.
Additional file 2: Table S2. Sex-biased genes in human BA.
Sex-biased genes detected by the microarray analysis in the postmortem
basal amygdala samples from healthy human subjects.
Additional file 3: Table S3. Sex-biased genes in human LA.
Sex-biased genes detected by the microarray analysis in the postmortem
lateral amygdala samples from healthy human subjects.
Additional file 4: Table S4. Sex-biased genes in mouse BLA.
Sex-biased genes detected by the microarray analysis in the basolateral
amygdala from adult C57BL/6J mice.
Additional file 5: Table S5. Sex-biased genes in mouse LA.
Sex-biased genes detected by the microarray analysis in the lateral
amygdala from adult C57BL/6J mice.
List of abbreviations used
ACC: anterior cingulate cortex; AChE: acetylcholinesterase; BA: basal
amygdala; BA9: Brodman area 9; BA47: Brodman area 47; BLA: basolateral
amygdala; ETC: electron transport chain; IPA: Ingenuity Pathways Analysis;
LA: lateral amygdala; qPCR: Real-time Quantitative PCR; RORB: retinoic acid
orphan receptor β; SIRT: sirtuin; THRA: thyroid hormone receptor α.
Acknowledgements
We gratefully acknowledge support of this research from NIMH (MH077159,
MH084060, MH085111), the University of Pittsburgh Brain Tissue Donation
Program (MH084053), and Xingbin Wang for statistical support.
Authors’ contributions
LCL and ES designed this study. LCL carried out the molecular experiments,
performed the statistical analysis and drafted the manuscript. DAL provided
technical and conceptual support for the human brain collection. The final
manuscript was written by LCL and ES. All authors have read, edited and
approved the final manuscript.
Competing interests
Dr. Lewis currently receives investigator-initiated research support from the
BMS Foundation, Bristol-Myers Squibb, Curridium Ltd and Pfizer and in 2007-
2010 served as a consultant in the areas of target identification and
Lin et al. Molecular Brain 2011, 4:18
http://www.molecularbrain.com/content/4/1/18
Page 5 of 6validation and new compound development to AstraZeneca, BioLine RX,
Bristol-Myers Squibb, Hoffman-Roche, Lilly, Merck, Neurogen, and SK Life
Science.
Received: 22 March 2011 Accepted: 4 May 2011 Published: 4 May 2011
References
1. Kendler KS: Gender differences in the genetic epidemiology of major
depression. J Gend Specif Med 1998, 1(2):28-31.
2. Tondo L, Baldessarini RJ: Rapid cycling in women and men with bipolar
manic-depressive disorders. The American journal of psychiatry 1998,
155(10):1434-1436.
3. Jazin E, Cahill L: Sex differences in molecular neuroscience: from fruit
flies to humans. Nature reviews 11(1):9-17.
4. Hines M, Allen LS, Gorski RA: Sex differences in subregions of the medial
nucleus of the amygdala and the bed nucleus of the stria terminalis of
the rat. Brain research 1992, 579(2):321-326.
5. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA:
Increased amygdala response to masked emotional faces in depressed
subjects resolves with antidepressant treatment: an fMRI study. Biological
psychiatry 2001, 50(9):651-658.
6. Sibille E, Wang Y, Joeyen-Waldorf J, Gaiteri C, Surget A, Oh S, Belzung C,
Tseng GC, Lewis DA: A molecular signature of depression in the
amygdala. The American journal of psychiatry 2009, 166(9):1011-1024.
7. Svendsen CN, Bird ED: Acetylcholinesterase staining of the human
amygdala. Neuroscience letters 1985, 54(2-3):313-318.
8. Kitt CA, Hohmann C, Coyle JT, Price DL: Cholinergic innervation of mouse
forebrain structures. The Journal of comparative neurology 1994,
341(1):117-129.
9. The Ingenuity Pathways Knowledge Base. [http://www.ingenuity.com/].
10. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F,
Mostoslavsky R, Alt FW, Schibler U: SIRT1 regulates circadian clock gene
expression through PER2 deacetylation. Cell 2008, 134(2):317-328.
11. Yang X, Downes M, Yu RT, Bookout AL, He W, Straume M, Mangelsdorf DJ,
Evans RM: Nuclear receptor expression links the circadian clock to
metabolism. Cell 2006, 126(4):801-810.
12. Galfalvy HC, Erraji-Benchekroun L, Smyrniotopoulos P, Pavlidis P, Ellis SP,
Mann JJ, Sibille E, Arango V: Sex genes for genomic analysis in human
brain: internal controls for comparison of probe level data extraction.
BMC bioinformatics 2003, 4:37.
13. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V,
Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, Vitaterna MH, Orsulak P,
Takahashi JS, Nestler EJ, Carlezon WA Jr, McClung CA: Mania-like behavior
induced by disruption of CLOCK. Proceedings of the National Academy of
Sciences of the United States of America 2007, 104(15):6406-6411.
14. Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S,
Brunk I, Spanagel R, Ahnert-Hilger G, Meijer JH, Albrecht U: Regulation of
monoamine oxidase A by circadian-clock components implies clock
influence on mood. Curr Biol 2008, 18(9):678-683.
15. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C,
Gutierrez-Zotes A, Puigdemont D, Bayes M, Crespo JM, Martorell L, Vilella E,
Labad A, Vallejo J, Pérez V, Menchón JM, Estivill X, Gratacòs M,
Urretavizcaya M: Differential association of circadian genes with mood
disorders: CRY1 and NPAS2 are associated with unipolar major
depression and CLOCK and VIP with bipolar disorder.
Neuropsychopharmacology 35(6):1279-1289.
16. Abe N, Uchida S, Otsuki K, Hobara T, Yamagata H, Higuchi F, Shibata T,
Watanabe Y: Altered sirtuin deacetylase gene expression in patients with
a mood disorder. Journal of psychiatric research .
17. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S:
Molecular evidence for mitochondrial dysfunction in bipolar disorder.
Archives of general psychiatry 2004, 61(3):300-308.
18. Rollins B, Martin MV, Sequeira PA, Moon EA, Morgan LZ, Watson SJ,
Schatzberg A, Akil H, Myers RM, Jones EG, Wallace DC, Bunney WE,
Vawter MP: Mitochondrial variants in schizophrenia, bipolar disorder, and
major depressive disorder. PloS one 2009, 4(3):e4913.
19. Fattal O, Link J, Quinn K, Cohen BH, Franco K: Psychiatric comorbidity in
36 adults with mitochondrial cytopathies. CNS spectrums 2007,
12(6):429-438.
doi:10.1186/1756-6606-4-18
Cite this article as: Lin et al.: A human-mouse conserved sex bias in
amygdala gene expression related to circadian clock and energy
metabolism. Molecular Brain 2011 4:18.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lin et al. Molecular Brain 2011, 4:18
http://www.molecularbrain.com/content/4/1/18
Page 6 of 6